54-280

Utilidad de la procalcitonina sérica para la discriminación temprana entre fascitis necrosante y celulitis de las extremidades: serie de casos y revisión de la literatura.

SALAZAR J1, NOVOA-PARRA C 2; WADHWANI J1, MONTANER-ALONSO D1; RODRIGO-PÉREZ J1
Recepción:
14/03/2020
Aceptación:
14/03/2020
Publicación:
14/03/2020


Métricas


77

Visualizaciones


1

Descargas


Compartir

Compartir

Resumen (ES)

Objective: to assess the usefulness of a risk scale based on serum procalcitonin when compared with the LRINEC scorein the early discrimination between necrotizing fasciitis (NF) and extremities cellulite.Material and method: retrospective study, between 2009 and 2017, of all patients with the confirmed diagnosis of NF inone limb (N = 10). The findings of these patients were compared with those of 23 patients who were admitted for severecellulitis of limbs in the same period. The variables related to each group were analyzed. Using the area under the curve(AUC), the discrimination capacity for NF diagnosis of two scales was compared, one based on procalcitonin levels andanother based on the LRINEC score.Results: the area under the curve was greater for the risk categorized by procalcitonin levels. When analyzing the LRINECscore and procalcitonin levels as continuous variables, the latter also presented a larger area under the curve. The cut-offpoint with the greatest area under the curve was that corresponding to> 0.87 ng / ml of procalcitonin (sensitivity of 100%and specificity of 82.6%) and score 5 on the LRINEC score (sensitivity of 80% and specificity of 82.6%).Conclusion: in our sample the level of procalcitonin and the scale based on this level has been shown as a more sensitiveand at least as specific tool as the LRINEC scale for early discrimination between NF and a cellulite of the extremities.

Palabras clave (ES):

Procalcitonina
Fascitis
Celulitis
necrosante

Resumen (EN)

Objective: to assess the usefulness of a risk scale based on serum procalcitonin when compared with the LRINEC scorein the early discrimination between necrotizing fasciitis (NF) and extremities cellulite.Material and method: retrospective study, between 2009 and 2017, of all patients with the confirmed diagnosis of NF inone limb (N = 10). The findings of these patients were compared with those of 23 patients who were admitted for severecellulitis of limbs in the same period. The variables related to each group were analyzed. Using the area under the curve(AUC), the discrimination capacity for NF diagnosis of two scales was compared, one based on procalcitonin levels andanother based on the LRINEC score.Results: the area under the curve was greater for the risk categorized by procalcitonin levels. When analyzing the LRINECscore and procalcitonin levels as continuous variables, the latter also presented a larger area under the curve. The cut-offpoint with the greatest area under the curve was that corresponding to> 0.87 ng / ml of procalcitonin (sensitivity of 100%and specificity of 82.6%) and score 5 on the LRINEC score (sensitivity of 80% and specificity of 82.6%).Conclusion: in our sample the level of procalcitonin and the scale based on this level has been shown as a more sensitiveand at least as specific tool as the LRINEC scale for early discrimination between NF and a cellulite of the extremities.

Explorar

Artículos


Volúmenes


Sobre la revista


Más leídos

Surgiceloma como complicación de tenodesis extraarticular de Lemaire modificada asociada a ligamentoplastia del cruzado anterior

Revista Española de Cirugía Osteoarticular


Uso de placa puente dorsal: una alternativa en fracturas de muñeca catastróficas

Revista Española de Cirugía Osteoarticular


No todo es "cut-out": reclasificación de las complicaciones mecánicas del tornillo cefálico del clavo intramedular.

Revista Española de Cirugía Osteoarticular


Solución límite para recambio de prótesis total de cadera con cotilo osteointegrado: presentación de casos

Revista Española de Cirugía Osteoarticular


Radioterapia a bajas dosis en artrosis: ¿una opción terapéutica real o un efecto placebo sofisticado?

Revista Española de Cirugía Osteoarticular